Main Menu

Taro Pharmaceutical Industries Ltd.

(NYSE: TARO)

Rigrodsky Law, P.A. is investigating Taro Pharmaceutical Industries Ltd. (“Taro”) regarding possible breaches of fiduciary duties and other violations of law related to Taro’s agreement to be acquired by Sun Pharmaceutical Industries Limited. Under the terms of the agreement, Taro shareholders will receive $43.00 per share in cash.

Join This Action

Alternatively, you may upload your transactions using the upload button below or email them to info@rl-legal.com.

Draw your signature below using your mouse* [Clear]

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

Date of signing: 03/02/2024


* Indicates a required field.

Back to Page